CSF copper concentrations in chronic schizophrenia
| Autor: | Torrey Ef, Raghunath P. Agarwal, Daniel R. Weinberger, Steven G. Potkin, David Shore, Robert I. Henkin, Wyatt Rj, Gillin Jc |
|---|---|
| Rok vydání: | 1983 |
| Předmět: |
Adult
Male medicine.medical_specialty Patient subgroups chemistry.chemical_element Length of hospitalization Computed tomography Gastroenterology Sex Factors Internal medicine medicine Humans Copper levels Platelet monoamine oxidase Heroin addicts medicine.diagnostic_test Heroin Dependence business.industry Copper Psychiatry and Mental health chemistry Chronic Disease Schizophrenia Female Chronic schizophrenia business Antipsychotic Agents |
| Zdroj: | Europe PubMed Central |
| ISSN: | 1535-7228 0002-953X |
| DOI: | 10.1176/ajp.140.6.754 |
| Popis: | The authors used a sensitive flameless atomic absorption spectrophotometric procedure to measure CSF copper concentrations in normal controls, former heroin addicts, and unmedicated and medicated chronic schizophrenic patients and found no significant differences in CSF copper levels between these groups. Schizophrenic women had significantly lower CSF copper levels than schizophrenic men, but no significant differences were found between control men and control women. There were no differences in CSF copper levels between patient subgroups with respect to diagnostic subtype (acute versus chronic, paranoid versus chronic undifferentiated), length of hospitalization, race, medication status, platelet monoamine oxidase values, or CAT scan abnormalities. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|